| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cara Therapeutics, Inc. | Director | Common Stock | 411,007 | $308,255 | $0.7500 | 04 Jun 2024 | Direct |
| Cara Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 390,000 | 04 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TVRD | Cara Therapeutics, Inc. | 04 Jun 2024 | 2 | $0 | 4 | Director | 06 Jun 2024, 16:22 |
| TVRD | Cara Therapeutics, Inc. | 01 Jun 2023 | 2 | $0 | 4 | Director | 05 Jun 2023, 16:29 |
| TVRD | Cara Therapeutics, Inc. | 14 Sep 2022 | 1 | -$111,024 | 4 | Director | 16 Sep 2022, 16:21 |
| TVRD | Cara Therapeutics, Inc. | 02 Jun 2022 | 3 | $0 | 4 | Director | 06 Jun 2022, 17:49 |
| TVRD | Cara Therapeutics, Inc. | 03 Jun 2021 | 3 | -$112,752 | 4 | Director | 07 Jun 2021, 19:35 |